Safety of COVID-19 vaccination in patients with clonal mast cell disorders

被引：8
|
作者：
Ruano-Zaragoza, Maria [1 ,2 ]
Carpio-Escalona, Laura V. [3 ]
Diaz-Beya, Marina [4 ]
Piris-Villaespesa, Miguel [5 ]
Castano-Diez, Sandra [4 ]
Munoz-Cano, Rosa [1 ,2 ]
Gonzalez-de-Olano, David [2 ,3 ]
机构：
[1] Univ Barcelona, Hosp Clin, Allergy Sect, IRCE Inst dInvest Biomed August Pi Sunyer, C Villarroel,170, Barcelona 08036, Spain
[2] Inst Salud Carlos III, ARADyAL, Madrid, Spain
[3] Hosp Univ Ramon & Cajal, Allergy Dept, IRYCIS, Carretera Colmenar Viejo Km 9 1, Madrid 28034, Spain
[4] Hosp Clin Barcelona, Dept Hematol, Barcelona, Spain
[5] Hosp Univ Ramon & Cajal, Dept Hematol, IRYCIS, Madrid, Spain
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE | 2022年 / 10卷 / 05期
关键词：
MASTOCYTOSIS;
D O I：
10.1016/j.jaip.2022.01.030
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：1374 / +
页数：4
相关论文
共 50 条
  • [1] Outcomes of COVID-19 vaccination in 323 patients with clonal and non-clonal mast cell activation disorders
    Giannetti, Matthew P.
    Olivieri, Francesco
    Godwin, Grace
    Weller, Emma
    Nicoloro-SantaBarbara, Jennifer
    Bonadonna, Patrizia
    Zanotti, Roberta
    Zanoni, Giovanna
    Hartmann, Karin
    Castells, Mariana
    ALLERGY, 2023, 78 (01) : 301 - 304
  • [2] Safety of COVID-19 vaccination in children with prior allergic reactions or mast cell disorders
    Kulkarni, Rishabh
    Arnold, Annabelle
    Buzynski, Adrian
    Lucas, Michaela
    CLINICAL AND TRANSLATIONAL ALLERGY, 2023, 13 (05)
  • [3] Safety of COVID-19 vaccination in patients with mastocytosis and monoclonal mast cell activation syndrome
    Kaakati, Rayan
    Khokhar, Dilawar
    Akin, Cem
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (08): : 3198 - 3199
  • [4] Tolerability of COVID-19 Vaccination in Patients with Mast Cell Activation
    Macdougall, Jessica
    Amelio, Claire
    Kwan, Mildred
    Iweala, Onyinye
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB321 - AB321
  • [5] Safety of COVID-19 mRNA vaccination and effects of SARS-CoV-2 infection in children and adults with mast cell disorders
    Catherine K. Zhu
    Alex Nguyen
    Connor Prosty
    Sofianne Gabrielli
    Pasquale Mulé
    Elena Netchiporouk
    Michelle Le
    Xun Zhang
    Greg Shand
    Sharon Baum
    Reman Hakroush
    Shoshana Greenberger
    Ayelet Ollech
    Barbara Miedzybrodzki
    Moshe Ben-Shoshan
    Clinical and Experimental Medicine, 2023, 23 (8) : 4937 - 4942
  • [6] Safety of COVID-19 mRNA vaccination and effects of SARS-CoV-2 infection in children and adults with mast cell disorders
    Zhu, Catherine K.
    Nguyen, Alex
    Prosty, Connor
    Gabrielli, Sofianne
    Mule, Pasquale
    Netchiporouk, Elena
    Le, Michelle
    Zhang, Xun
    Shand, Greg
    Baum, Sharon
    Hakroush, Reman
    Greenberger, Shoshana
    Ollech, Ayelet
    Miedzybrodzki, Barbara
    Ben-Shoshan, Moshe
    CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 23 (08) : 4937 - 4942
  • [7] Safety of BNT162b2 mRNA COVID-19 vaccine in patients with mast cell disorders
    Rosman, Yossi
    Lavi, Noa
    Meir-Shafrir, Keren
    Lachover-Roth, Idit
    Cohen-Engler, Anat
    Mekori, Yoseph A.
    Confino-Cohen, Ronit
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (09): : 3487 - 3489
  • [8] Delving Into COVID-19 Vaccination-Induced Anaphylaxis: Are mRNA Vaccines Safe in Mast Cell Disorders?
    Azenha Rama, T.
    Alvarez-Twose, I
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2021, 31 (02) : 193 - 195
  • [9] Safety and immunogenicity of COVID-19 vaccination in immunocompromised patients
    Song, Jin-Wen
    Hu, Wei
    Shen, Lili
    Wang, Fu-Sheng
    CHINESE MEDICAL JOURNAL, 2022, 135 (22) : 2656 - 2666
  • [10] Safety of intramuscular COVID-19 vaccination in patients with haemophilia
    Tiede, Andreas
    Leise, Hendrik
    Horneff, Silvia
    Oldenburg, Johannes
    Halimeh, Susan
    Heller, Christine
    Koenigs, Christoph
    Holstein, Katharina
    Pfrepper, Christian
    HAEMOPHILIA, 2022, 28 (05) : 687 - 693
12345